Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Storer

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Statistics in Medicine|August 21, 2001
An evaluation of phase I clinical trial designs in the continuous dose-response settingB E Storer
Biometrics|December 1, 1993
Small-sample confidence sets for the MTD in a phase I clinical trialB E Storer
Biometrics|March 1, 1992
A class of phase II designs with three possible outcomesB E Storer
Statistics in Medicine|March 1, 1990
A sequential phase II/III trial for binary outcomesB E Storer
Biometrics|September 1, 1989
Design and analysis of phase I clinical trialsB E Storer
Lancet (London, England)|December 20, 1980
Excess of malignant melanomas in women in the British IslesJ A Lee, B E Storer
American Journal of Epidemiology|July 1, 1985
General relative risk functions for case-control studiesN E Breslow, B E Storer
Journal of the National Cancer Institute|July 19, 1995
Postmenopausal hormone use and risk of large-bowel cancerP A Newcomb, B E Storer
International Journal of Epidemiology|June 1, 1982
Further studies on skin melanomas apparently dependent on female sex hormonesJ A Lee, B E Storer
Lancet (London, England)|June 27, 1981
Malignant melanoma female/male death ratiosJ A Lee, B E Storer
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Statistics in Medicine|August 21, 2001
An evaluation of phase I clinical trial designs in the continuous dose-response settingB E Storer
Biometrics|December 1, 1993
Small-sample confidence sets for the MTD in a phase I clinical trialB E Storer
Biometrics|March 1, 1992
A class of phase II designs with three possible outcomesB E Storer
Statistics in Medicine|March 1, 1990
A sequential phase II/III trial for binary outcomesB E Storer
Biometrics|September 1, 1989
Design and analysis of phase I clinical trialsB E Storer
Lancet (London, England)|December 20, 1980
Excess of malignant melanomas in women in the British IslesJ A Lee, B E Storer
American Journal of Epidemiology|July 1, 1985
General relative risk functions for case-control studiesN E Breslow, B E Storer
Journal of the National Cancer Institute|July 19, 1995
Postmenopausal hormone use and risk of large-bowel cancerP A Newcomb, B E Storer
International Journal of Epidemiology|June 1, 1982
Further studies on skin melanomas apparently dependent on female sex hormonesJ A Lee, B E Storer
Lancet (London, England)|June 27, 1981
Malignant melanoma female/male death ratiosJ A Lee, B E Storer
Pageof 7